Physician-Supervised Peptide Program
Peptide Recovery Program
Supervised recovery and soft-tissue support — physician-directed, not self-managed.
A physician-supervised recovery-focused peptide program at EBO2 Therapy and Wellness. Candidacy, screening, and monitoring are handled through consultation and labs — recovery peptides are considered only when the supervising physician determines they fit your health profile.
Quick answer
A physician-supervised recovery-focused peptide program at EBO2 Therapy and Wellness. Candidacy, screening, and monitoring are handled through consultation and labs — recovery peptides are considered only when the supervising physician determines they fit your health profile. Supervised recovery and soft-tissue support — physician-directed, not self-managed.
Program Overview
A supervised program, not an off-the-shelf product
The Peptide Recovery Program is built for clients who want a physician-supervised approach to recovery from training, effort, or the wear of an active life — rather than piecing together a self-directed stack from the internet.
Every program starts with an in-person or virtual consultation and baseline labs. The supervising physician reviews your history, current medications, activity patterns, and any prior injuries before considering whether a recovery-focused peptide is appropriate.
This page describes how the program is built. It does not claim any peptide heals a specific injury or diagnosis. Injury management and diagnostic work belong with your primary or specialty providers.
Who It's Considered For
- Active adults recovering from consistent training loads who want physician oversight
- Concierge clients pairing supervised recovery peptides with EBO3, IV therapy, HBOT, or Red Light
- Patients who prefer a lab-guided plan and structured follow-up over a self-managed stack
- Individuals who understand peptides are one adjunct inside a broader recovery plan — not injury or disease treatment
Medical Oversight
Physician-directed from consultation onward
A supervising physician at EBO2 Therapy and Wellness directs every step: intake, labs, program design, cadence, follow-up, and any pause or discontinuation. Recovery peptides are added only if the physician judges consideration appropriate — and only inside a broader plan that also respects rest, sleep, load management, and rehab work handled elsewhere.
Options a Physician May Consider
Peptides studied inside this category
Depending on your consultation and labs, the physician may consider one of the following categories inside a broader recovery plan. These are options the physician may consider — not a menu you order from.
BPC-157
A short peptide researched for soft-tissue and gastrointestinal signaling. Consideration, cadence, and route are entirely at physician discretion after screening.
TB-500 (thymosin beta-4 fragment)
Studied for tissue and cell migration signaling. Whether it is appropriate for your profile, and how, is a physician decision.
KPV
A short tripeptide fragment researched in the context of inflammation modulation. Consideration and cadence are at physician discretion after labs and history.
Listing here is educational only. Availability of any specific peptide, and whether it is appropriate for you, is determined by the supervising physician after consultation and labs. No outcome is promised, and no FDA approval is claimed for any wellness protocol.
How the Program Starts
Consult → labs → individualized plan
Step 1
Consultation
Private intake and physician review — goals, medical history, current medications, prior injuries, training and recovery patterns.
Step 2
Baseline labs
Ordered before any peptide is considered. Results and history anchor the physician's plan.
Step 3
Individualized plan
Physician determines whether a peptide is appropriate, which category, cadence, and how it sits inside your broader recovery approach.
Step 4
Follow-up
Interval reviews and labs on the physician's cadence. Adjustments, pauses, and discontinuations are all part of the plan.
Program length: Recovery programs are typically defined cycles rather than open-ended use. Length, cadence, and any transition are directed by the supervising physician based on how you respond and what your labs show.
Safety & Oversight
Non-negotiables of the program
- Baseline and interval labs are required — no peptide is added on assumption.
- The physician alone determines what is used, at what cadence, and when to pause or stop.
- Pregnancy, breastfeeding, active cancer, and certain conditions or medications may exclude or modify options.
- Any new symptom, injury, or diagnostic question is reviewed with the clinical team before the next dose.
- The program supports — but does not replace — care from your primary, orthopedic, or specialty providers.
No FDA approval is claimed for any wellness protocol. No specific injury-treatment or cure outcome is promised.
What Programs Cost
Discussed at consultation
Program pricing is discussed at consultation and depends on the physician's plan, labs cadence, and program length. Pricing reflects a supervised program — not a product purchase.
Related Peptide Programs
Explore other physician-supervised tracks
Weight Management Program
Physician-supervised GLP-1 and advanced options reviewed after labs.
Learn more →
Cellular Longevity Program
Mitochondrial-focused longevity peptides considered under supervision.
Learn more →
Energy & Vitality Program
Physician-guided peptides for energy, sleep quality, and daily vitality.
Learn more →
FAQ
Common Questions About the Peptide Recovery Program
Who is a candidate for the Peptide Recovery Program?
How does the program start?
How long does the program run?
How is safety monitored?
What does the program cost?
Is this program a treatment for injuries?
Begin Your Journey
Ask about the Peptide Recovery Program
Programs start with a private consultation, labs, and a physician-directed plan — not a checkout.
Available at our clinics
Peptide Therapy in California & Florida
Explore peptide therapy at each EBO2 Therapy and Wellness location, or dig into a side-by-side comparison and the clinical guide.
Medically reviewed by Daniel Moghadam, MD.
Page updated: July 2026
This page is maintained by EBO2 Therapy and Wellness to answer common questions about Peptide Recovery Program. Content is educational and is not a substitute for consultation, screening, and provider guidance. See the full Medical Disclaimer at the end of this page.
How candidacy for Peptide Recovery Program is evaluated
- Medical history, current medications, and prior labs are reviewed at consultation.
- Baseline labs are ordered before any peptide program is started.
- Pregnancy, breastfeeding, active cancer, and certain conditions may exclude or modify options.
- Selection of any specific peptide, dose, and cadence is entirely at physician discretion.
- Peptide programs are wellness-focused and are not a substitute for medical care; results vary.
Screening, history, and provider guidance determine whether any protocol is appropriate for a given individual. Results vary.
Where this information comes from
FDA approvals for GLP-1 products such as WEGOVY are specific to a particular product, route, dose, and indication and do NOT transfer to compounded semaglutide, unapproved GLP-1 formulations, or investigational peptide stacks (e.g. BPC-157, MOTS-c, TB-500). FDA has flagged dosing errors with compounded semaglutide and safety risks with several bulk peptide substances. Programs at EBO2 remain physician-supervised.
- WEGOVY (semaglutide) — FDA prescribing label
DailyMed (U.S. National Library of Medicine)
Current FDA-approved prescribing information for WEGOVY, defining approved indication, dosing, route, and safety information. Approval is product/route/indication-specific.
- FDA alerts providers, compounders, and patients to dosing errors with compounded semaglutide
U.S. Food & Drug Administration
FDA safety alert on dosing errors associated with compounded semaglutide. Regulatory/safety context only; does not endorse compounded products.
- FDA intends to take action against non-FDA-approved GLP-1 drugs
U.S. Food & Drug Administration
FDA statement on planned enforcement against non-FDA-approved GLP-1 products. Regulatory context; not a recommendation for any specific program.
- FDA — Certain Bulk Drug Substances Used to Compound Drug Products May Present Significant Safety Risks
U.S. Food & Drug Administration
FDA safety-risk framing for bulk drug substances used in compounding — the category that covers BPC-157, MOTS-c, TB-500, and related investigational peptides. Risk/regulatory context only.
- FDA — Unapproved Drugs enforcement policy overview
U.S. Food & Drug Administration
FDA overview of how the agency treats drugs that lack FDA approval, providing regulatory context for compounded and unapproved products.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.